Tabuteau Herriot's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Oct 8, 2025
- Accession no.
- 0001193125-25-234881
- Filed
- Oct 8, 2025
- Trade date
- Oct 6-8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $5.42M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tabuteau HerriotCIK 0001219927 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | MOption exerciseAcquired | +19,220 | $8.02 | +$154,144.4 | 26,449 | Direct | |
| Oct 6, 2025 | Common Stock | SSaleDisposed | −19,220 | $120.17F4 | −$2,309,667.4 | 7,229 | Direct | |
| Oct 7, 2025 | Common Stock | MOption exerciseAcquired | +13,390 | $8.02 | +$107,387.8 | 20,619 | Direct | |
| Oct 7, 2025 | Common Stock | SSaleDisposed | −13,390 | $118.77F5 | −$1,590,330.3 | 7,229 | Direct | |
| Oct 8, 2025 | Common Stock | MOption exerciseAcquired | +12,774 | $8.02 | +$102,447.48 | 20,003 | Direct | |
| Oct 8, 2025 | Common Stock | SSaleDisposed | −12,774 | $118.84F6 | −$1,518,062.16 | 7,229 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | MOption exerciseDisposed | −19,220 | $0.00 | $0 | 441,900 | Direct | |
| Oct 7, 2025 | Common Stock | MOption exerciseDisposed | −13,390 | $0.00 | $0 | 428,510 | Direct | |
| Oct 8, 2025 | Common Stock | MOption exerciseDisposed | −12,774 | $0.00 | $0 | 415,736 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $119.62 and $120.67.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $117.53 and $119.66.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $117.73 and $119.96.
Referenced by the price of 1 transaction in Table I.